Clinical Research, Pharma & Healthcare FinancingEU Approves Guerbet Elucirem™ Half-Dose for Children from BirthPR NewswireJanuary 28, 2026January 29, 2026 by PR NewswireJanuary 28, 2026January 29, 2026037 Guerbet (FR0000032526 GBT), a global specialist in contrast media and solutions for medical imaging, is delighted to announce the approval by European Commission of a...